Vox sanguinis · 2025
Forecasting emerging trends in transfusion medicine through complex network analysis of scholars' research.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Feng, He Xu, Zhang Huifang, Huang Yi
Аннотация
BACKGROUND AND OBJECTIVES: This study aimed to analyse and predict emerging trends in transfusion medicine using complex network analysis of high-impact global scholar rankings.
MATERIALS AND METHODS: Network analysis was employed to uncover research trends, identify central research directions and map knowledge networks. The analytical hierarchy process was used to evaluate potential future research trajectories. The Kolmogorov-Smirnov test assessed network centrality differences, with cross-validation performed using the Association for the Advancement of Blood & Biotherapies (AABB) and the International Society of Blood Transfusion (ISBT) conference themes.
RESULTS: Clinical transfusion is the central theme, with transfusion management, evaluation and specific transfusions like platelet and plasma gaining prominence. Blood safety evolved into a standalone domain, while immunohaematology and cell therapy represent emerging trends. Innovations in blood storage, transfusion technology and omics insights are shaping future directions. Notably, despite global healthcare impacts, COVID-19 has not significantly redirected transfusion medicine research.
CONCLUSION: The transfusion medicine landscape demonstrates stability in its core framework while increasingly focusing on emerging areas such as personalized therapies, platelet transfusion and cell-based treatments.
MATERIALS AND METHODS: Network analysis was employed to uncover research trends, identify central research directions and map knowledge networks. The analytical hierarchy process was used to evaluate potential future research trajectories. The Kolmogorov-Smirnov test assessed network centrality differences, with cross-validation performed using the Association for the Advancement of Blood & Biotherapies (AABB) and the International Society of Blood Transfusion (ISBT) conference themes.
RESULTS: Clinical transfusion is the central theme, with transfusion management, evaluation and specific transfusions like platelet and plasma gaining prominence. Blood safety evolved into a standalone domain, while immunohaematology and cell therapy represent emerging trends. Innovations in blood storage, transfusion technology and omics insights are shaping future directions. Notably, despite global healthcare impacts, COVID-19 has not significantly redirected transfusion medicine research.
CONCLUSION: The transfusion medicine landscape demonstrates stability in its core framework while increasingly focusing on emerging areas such as personalized therapies, platelet transfusion and cell-based treatments.